CVE-2026-24231NVIDIA NemoClaw contains a vulnerability in the validateEndpointUrl() SSRF protection component, where an attacker could cause a server-side request forgery by supplying a crafted endpoint URL refere…
Updated under an hour ago ()
Does this affect you?
It affects nvidia nemoclaw. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
NVIDIA NemoClaw contains a vulnerability in the validateEndpointUrl() SSRF protection component, where an attacker could cause a server-side request forgery by supplying a crafted endpoint URL referencing the 0.0.0.0/8 address range through a blueprint configuration file or CLI flag. A successful exploit of this vulnerability may lead to information disclosure.
- CVSS
- 6.3 MEDIUM (v3.1, NVD)CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:C/C:H/I:N/A:N
- Weakness (CWE)
- CWE-918
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- Not given
- NVD analysis
- Analyzed
- Record last updated
- Jun 17, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
nvidia nemoclaw nvidia:nemoclaw | before 0.0.13 | NVD |
References
- https://nvd.nist.gov/vuln/detail/CVE-2026-24231us-government-resource
- https://nvidia.custhelp.com/app/answers/detail/a_id/5837vendor-advisory
- https://www.cve.org/CVERecord?id=CVE-2026-24231third-party-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.